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Purpose
Circulating immune complexes (CICs) from juvenile
idiopathic arthritis (JIA) sera have been shown to con-
tain bound complement components; however, whether
the classical or alternative pathway is the main pathway
involved remains undetermined. To delineate the role of
these pathways in the disease process, we measured acti-
vated complement products bound to CICs in sera from
100 JIA patients.
Methods
Sera from 100 JIA patients were collected, including 68
polyarthritis (41 IgM RF-negative and 27 IgM RF-positive)
and 32 oligoarthritis patients. Sera from 17 healthy chil-
dren were also analyzed. C1q, C3, C3d, C4, and membrane
attack complex (MAC) bound to CICs were measured by
enzyme-linked immunosorbent assay (ELISA). IgA and
IgM RF and IgG anti-cyclic citrullinated peptide (anti-
CCP) antibodies were also measured by ELISA. C-reactive
protein (CRP), erythrocyte sedimentation rate (ESR), and
disease activity were obtained from patient records.
Results
C1q and C4 bound to CICs had the highest percent of
positivity in the JIA population (48% and 45%, respec-
tively). C3 and C3d bound to CICs were positive in 36%
and 25% of JIA patients, respectively. MAC bound to
CICs was positive in 29% of patients. Levels of C1q, C4,
C3 and MAC bound to CICs were all significantly ele-
vated in JIA patients when compared to healthy controls
(p<0.05). However, C3 levels remained normal in both
JIA and healthy children. No significant differences were
noted between JIA subtypes, with both polyarticular and
oligoarticular subtypes favoring classical pathway activa-
tion. Strong correlations were noted between C1q and
C4 bound to CICs (r=0.76), C1q and MAC bound to
CICs (r=0.65), and C4 and MAC bound to CICs (r=0.66)
(p<0.05). IgM RF correlated significantly with C4 bound
to CICs (r=0.22, p=0.03). Of the 29 JIA patients positive
for MAC bound to CICs, 27 (93%) were also positive for
C1q bound to CICs, C4 bound to CICs, or both. Conver-
sely, only 16/29 (55%) of JIA patients positive for MAC
bound to CICs were positive for C3 bound to CICs, C3d
bound to CICs, or both.
Conclusion
These results indicate that the classical complement path-
way is the primary pathway involved in the pathogenesis
of JIA. While previous studies have implicated the classical
pathway with smaller study populations, our study is one
of the largest complement studies in JIA to indicate domi-
nance of the classical pathway in JIA. Due to the amplifi-
cation loop and higher levels of alternative pathway
proteins in plasma, elevated levels of alternative pathway
components are expected. MAC has received far less
attention in JIA studies. Our study found 29% of JIA2Saint Louis University, St. Louis, MO, USA
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patients positive for MAC bound to CICs. These results
largely the activation of the classical pathway by CICs in
the sera from patients with JIA.
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